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ABSTRACT
SUBUDHI, A. W., K. A. JACOBS, T. A. HAGOBIAN, J. A. FATTOR, S. R. MUZA, C. S. FULCO, A. CYMERMAN, and A. L.
FRIEDLANDER. Changes in Ventilatory Threshold at High Altitude: Effect of Antioxidants. Med. Sci. Sports Exerc., Vol. 38, No. 8,
pp. 1425-1431, 2006. Purpose: To investigate the effects of prolonged hypoxia and antioxidant supplementation on ventilatory
threshold (VT) during high-altitude (HA) exposure (4300 m). Methods: Sixteen physically fit males (25 ± 5 yr; 77.8 ± 8.5 kg)

performed an incremental test to maximal exertion on a cycle ergometer at sea level (SL). Subjects were then matched on VO2peak,
ventilatory chemosensitivity, and body mass and assigned to either a placebo (PL) or antioxidant (AO) supplement group in a
randomized, double-blind manner. PL or AO (12 mg of 0-carotene, 180 mg of a-tocopherol acetate, 500 mg of ascorbic acid, 100 ftg
of selenium, and 30 mg of zinc daily) were taken 21 d prior to and for 14 d at HA. During HA, subjects participated in an exercise
program designed to achieve an energy deficit of approximately 1400 kcal.d-1. VT was reassessed on the second and ninth days at
HA (HA2, HA9). Results: Peak power output (Wpeak) and VO2p,ak decreased (28%) in both groups upon acute altitude exposure
(HA2) and were unchanged with acclimatization and exercise (HA9). Power output at VT (WvT) decreased from SL to HA2 by 41%
in PL, but only 32% in AO (P < 0.05). WvT increased in PL only during acclimatization (P < 0.05) and matched AO at HA9. Similar
results were found when VT was expressed in terms of % Wpeak and % VO2peak. Conclusions: VT decreases upon acute HA exposure
but improves with acclimatization. Prior AO supplementation improves VT upon acute, but not chronic altitude exposure. Key
Words: HYPOXIA, FREE RADICAL, VO 2 -ax, ANAEROBIC THRESHOLD, LACTATE THRESHOLD
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overall predictor of performance among populations of
varied fitness levels, it fails to predict performance among
more homogeneous groups of trained individuals (4).
Several authors have reported that nonlinear increases in
physiological variables, such as blood lactate, HR, and
ventilation observed during progressive exercise tests
represent "thresholds" that are better predictors of performance than VO2peak (4) and accurately reflect work
rates during actual competition (16).
At high altitude (HA), aerobic exercise performance is
substantially compromised due to low ambient partial pressure of oxygen. Decrements in performance are greatest
upon initial exposure to hypoxia, yet improve with acclimatization (3,12,17). Because physiological thresholds are
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associated with prediction of performance (4), it may
seem logical that the lactate response to exercise follows a
similar pattern of acclimatization (11); however, the
mechanisms responsible for decreased blood lactate concentrations during exercise following acclimatization
remain paradoxical in light of persistent hypoxemia (24).
Given the complexities of lactate kinetics during exercise
at altitude, investigation of other related variables (e.g.,
ventilation, HR) has attracted attention.
Lactate ions (La-) are exported simultaneously with
protons (H+) across myocyte membranes; thus, their
accumulation in blood is well correlated during exercise
(27). Because H+ and CO 2 are potent simulators of
ventilation, nonlinear increases in ventilation (i.e., ventila
tory threshold (VT)) during incremental exercise tests have
been shown to be noninvasive alternatives to lactate thresh
old (LT) determinations (28). The mechanistic relationship
between VT and LT is a topic of great theoretical debate;
yet, from a practical standpoint, both variables have been
used successfully to longitudinally assess training status and
performance. Recently, Amann et al. (1) evaluated several
methods of assessing performance thresholds in a group of
trained individuals and reported that VT was the most
accurate and reliable index of laboratory cycling time-trial
performance. Additionally, Lucia et al. (16) reported that
VT was the only physiological variable obtained during an
incremental exercise test that was related to time-trial
performances during the Tour de France.

Despite the advantages of VT assessments, there have
been few measurements of VT at HA. Previous studies have
focused exclusively on the VT response to acute, but not
chronic hypoxia. Breathing reduced oxygen concentrations
(F 1 0 2 , 12-14%) during incremental exercise tests at low
altitude (8,13,21) and ascent from sea level (SL) to 4300 m
(6) has been shown to decrease VT by 18-33%. Such
results parallel changes observed in both LT (7,14,18) and
exercise performance (3,9) upon ascent to HA; however, to
our knowledge, no studies have described changes in VT
over a longer period of time to see whether VT follows a
similar pattern of improvement with acclimatization.
Strategies that improve physical performance under
hypoxic conditions are of great interest to those who work,
exercise, or compete at HA. Increased free radical
production at HA has been suggested to be responsible
for decrements in physical performance (2). Such findings
imply that scavenging free radicals with supplemental
antioxidants (AO) may improve exercise performance at
altitude, yet only one study has tested the effect of AO
supplementation on physical performance over an extended
stay at HA. Simon-Schnass and Pabst (25) studied the
effects of vitamin E in a group of HA mountaineers over
the course of a 10-wk expedition. After 4 wk at 5000 m,
subjects taking 400 mg.d-1 of a-tocopherol acetate
exhibited lower concentrations of oxidative stress markers
and a higher LT than those taking placebo. Unfortunately,
the study did not assess acute changes in LT over the
acclimatization period and used an absolute blood lactate
concentration (4.0 mmol'L-1) to identify LT, a method
inherently confounded by the lactate paradox of HA (24).
Thus, the present investigation sought to investigate the
effects of AO supplementation on VT over the first 2 wk of
exposure to 4300 m. We hypothesized that VT would be
decreased upon acute altitude exposure and improved with
acclimatization and that AO supplementation would have
an ergogenic effect of increasing VT at HA.

METHODS
Subjects. Eighteen physically fit, altitude-naive men
were recruited from Stanford University and the surrounding
areas (Palo Alto/San Jose, CA) by flyers and advertisements
in local newspapers. Written informed consent was obtained
from all subjects following the institutional guidelines of
Stanford University and the U.S. Army Research Institute of
Environmental Medicine (USARIEM). All subjects were
nonsmokers in good overall health as determined by
health history questionnaire and medical evaluation.
Subjects participated in regular endurance (cycle) exercise
(> 6 h'wk-1), had maximal oxygen uptake (61O2 ,na >
50 mL.kg'-lmin-1), were able to cycle for 1 h at 70%
of peak wattage (Wpeak), and had normal body fat
composition (5-16%).
Sea-level phase. Subjects completed a 7-d diet and
weight-stabilization period prior to 5 d of baseline testing
at the clinical studies unit in the VA Palo Alto Health Care

System (Palo Alto, CA, 15-m elevation, atmospheric
pressure 748-762 torr). On the second day of sea-level
(SL) residence, subjects performed an incremental exercise
test to volitional exhaustion on an electronically braked
cycle ergometer (Lode Excalibur Sport, The Netherlands).
Following 10 min of warm-up at a self-selected work rate,
subjects cycled at 50, 100, and 150 W for 2 min each.
Work rate was then increased by 30 W every 2 min until
exhaustion. Objective criteria for determining maximal
effort included at least two of the following: 1) increased
work rate without corresponding increase in V0 2 , 2)
respiratory exchange quotient > 1.10, 3) a pedal cadence
< 50 rpm. During the test, ventilation, expired gas
concentrations, and HR were analyzed and averaged over
30-s periods using an automated system (Parvomedics
TrueMax 2400, Consentius Technologies, Sandy, UT).
VO2peak was determined as the highest 30-s value obtained.
VT was identified as the first systematic increase in
ventilatory equivalents of oxygen (VE/V0 2 ) without a
concomitant change in ventilatory equivalents of carbon
dioxide (VE/VCO 2), as described previously (1). Peak
power output was determined using methods described by
Kuipers et al. (15). Three weeks prior to the HA phase,
subjects were matched on age, body mass, V02peak, body
fat percentage, partial pressure of end-tidal CO 2 , and
hypoxic ventilatory response (as described in Muza et al.
(20)) and assigned to either an AO supplement or placebo
(PL) group in a double-blind fashion. Based on previous
research (22), a broad-based AO supplement consisting of
vitamins and minerals was formulated for this study.
Subjects were instructed to ingest supplements twice daily,
once in the morning and once in the evening, continuing
throughout the HA phase. The daily AO dose consisted
of 12 mg of 0-carotene, 500 mg of ascorbic acid, 180 mg
of a-tocopherol acetate, 100 ýtg of selenium, and 30 mg of
zinc. The PL was an identical-looking and -tasting
cellulose capsule.
HA phase. Approximately 6 wk after the SL phase,
subjects were flown to Colorado Springs, CO (1850 in),
where they spent the night in an apartment breathing
supplemental oxygen. Oxygen saturation was monitored
periodically by pulse oximetry (Nonin 8500, Nonin Medical,
Plymouth, MN) and maintained at approximately 97%. The
next morning, subjects' oxygen saturation levels were
sustained via bottled 100% 02 while they were driven to
the USARIEM Maher Memorial Altitude Laboratory on the
summit of Pikes Peak, CO (4300 m, atmospheric pressure
458-464 torr). Subjects resided at HA for 14 d while
participating in an exercise program designed to increase
total energy expenditure to approximately 1400 kcal.d-'
over SL values (40% of caloric intake). Subjects were
monitored and coached to achieve daily energy expenditure
goals using daily activity logs accounting for each 24-h
period in 15-min intervals via the Harris-Benedict equation
and appropriate activity factors. Dietary intake was
monitored and adjusted, depending on daily energy
expenditure, to maintain an energy deficit (-1400 kcal'd-t)
common to HA expeditions (29). Subjects were fed a

standardized diet throughout the study composed of, whole
foods (e.g., pasta, bagels, cereal) with modest levels of AO
(% RDA values: 154% vitamin A, 111% vitamin C, 107%
vitamin E, 100% zinc, 256% .selenium). VT tests were
repeated at HA on days 2 (HA2; 24 h of exposure) and 9
(HA9; 192 h of exposure) following a 24-h rest period.
Blood draws. Resting blood samples were obtained by
venipuncture to assess plasma concentrations of a limited
subset of AO contained in the supplement (a-tocopherol
and 3-carotene), markers of oxidative stress (plasma lipid
hydroperoxides, whole-blood reduced and oxidized
glutathione, glutathione peroxidase activity, and urinary
8-hydroxydeoxyguanosine), and red cell hemoglobin (Hb)
concentration as described previously (26).
Other assessments. As reported by Fulco et al. (9),
the overall study design incorporated 720-Id cycling timetrial tests at SL and HA to evaluate the effect of a
carbohydrate versus noncaloric drink solution on exercise
performance. Time trials were performed 24 h after VT
tests with a 7-d washout period between trials. Because
only eight subjects ingested the noncaloric drink solution
during the time trials, the sample size was insufficient to
test for effects of AO on cycling time-trial performance
(N = 4 AO vs N = 4 PL). A post hoc power analysis, using
effect sizes calculated from respective time-trial data,
indicated that 18 subjects (N = 9 AO vs N = 9 PL) would
have been necessary to detect a significant group x time
interaction (80% power with a = 0.05). With respect to this
limitation, data from the time-trial tests were used as
markers of submaximal performance at SL and altitude for
qualitative comparisons only.
Statistical analysis. All dependent variables were
evaluated for normality (skewness, kurtosis, and normal
Q-Q plots) to ensure assumptions were met for parametric
statistical analysis. Repeated-measures ANOVA was used
to test for differences between groups (AO vs PL) over
time (SL, HA2, HA9) (a = 0.05). Variables with significant
group x time interactions were subjected to post hoc
analysis using t-tests with Holm adjustments for multiple
comparisons. Data are reported as mean + SEM.

RESULTS
Data from two subjects were excluded from the analysis
because they did not complete all three VT tests. Thus,
data from 16 subjects (25 ± 1yr; 77.8 ± 2.1 kg; 178.1 -+1.0
cm) were analyzed (N = 7 PL, N = 9 AO). As previously
reported (26), subjects lost an average of 4.3 + 1.2 kg of
body mass during the 14-d altitude exposure. Weight loss
was similar between AO and PL groups while eating a diet
consisting of 67 + 5% carbohydrate, 22 + 5% fat, and 11 +
1% protein. The specific AO micronutrient content of the
diet was formulated to just meet RDA guidelines and
averaged (± SD) 1388 ± 302 ýLg of vitamin A, 99 + 12 mg
of vitamin C, 16 ± 5 mg of vitamin E, 149 + 27 jig of
selenium, and 11 -±2 mg of zinc. Antioxidant supplementation

increased plasma concentrations of respective lipid-soluble
vitamin concentrations (43% increase in a-tocopherol; 132%
increase in 3-carotene), but did not have an effect on bloodborne markers of oxidative stress (26). Red cell Hb
concentration increased progressively (P < 0.05) from
158.8 ± 3.9 mg'dL-1 at SL to 167.4 ± 3.3 mg'dL-1 at
HAl and 176.6 ± 4.0 mg.dL-l at HA13, but was not
affected by AO.
Sea level. At SL, subjects achieved an average peak
power output (Wpeak) of 354 ± 14 W, which was associated
with a maximal oxygen consumption (VO2peak) of 4.36 ±
0.15 L'min-1, ventilation (VEpeak) of 161 + 6 L-min-1, and
HR (HRpeak) of 185 ± 2 bpm (Fig. 1). Power output at VT
(WvT) was 244 + 14 W (69 + 2% Wpeak), equating to a
V0 2 (VO2vT) of 3.16 + 0.14 L'min-1 (72 ± 2% V02peak)
and HR (HRv-r) of 157 + 3 bpm (85 + 2% HRpeak) (Figs. 2-4).
There were no differences between groups.
HA2. Upon acute altitude exposure (24 h), there was a
28% decrease in maximal exercise capacity, as defined by
Wpeak and 'VO2peak (Fig. 1), which was coupled with a 7%
increase in VEpeak (173 + 7 L'min- 1) and a 5% decrease in
HRp,ak (176 + 2 bpm). There were no differences between
groups. Variables associated with VT (WvT, VO2vT, and
HRVT) were lower at HA2 compared with SL for both
groups (Figs. 2 and 4). Significant interactions between
groups over time revealed that absolute WVT (169 + 9 vs
140 ± 10 W), relative Wv-r (65 ± 2 vs 56 + 2% Wpeak), and
relative VO2vT (75 + 2 vs 68 + 2% VO2p,ak) were greater
for AO versus PL, respectively (Figs. 2 and 3).
HA9. After 9 d at HA, maximal exercise capacity
remained 28% lower than SL and unchanged from HA2
(Fig. 1). VEpeak (177 ± 5 L-min-1) was greater than SL but
not different from HA2. HRpeak (157 ± 3 bpm) was lower
than both SL and HA2. There were no differences between
groups in VO2 peak, VEpeak, and HRpeak. At VT, WvT and
"VO2vT remained lower than SL but had improved from
HA2, due to significant changes in the PL group (175 + 11
W and 2.37 + 0.14 L'min-., respectively) (Figs. 2 and 4).
Wvr and VO2vT in the AO group were unchanged from
HA2 (164 + 10 W and 2.33 ± 0.12 L'min-1, respectively).

In relative terms, WvT improved significantly from HA2,
again largely due to changes in the PL group (65 ± 2%
Wpeak) because AO values were unchanged (67 - 2%
Wpeak). Relative VO2vT (75 ± 2% VO2peak) was slightly
greater than SL and HA2, but not different between groups
(Fig. 3). HRvT (139 ± 3 bpm) was lower than both SL and
HA2, but similar between groups. Relative HRvT (88 ± 1%
HRpeak) was not different from SL or HA2.

DISCUSSION
The goal of this investigation was to determine the
effects of prolonged hypobaric hypoxia and AO supple
mentation on VT. We found that 1) VT was decreased
upon acute altitude exposure to 4300 m, yet improved with
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The decrement in VT at 4300 m was comparable with
other studies that reduced the fraction of inspired oxygen
(F1 0 2 12-14%) during incremental exercise tests (8,13,21).
Our study design most closely resembled that of Brutsaert
et al. (6), who measured VT in a group of SL natives after
approximately 10 h of exposure to 4338 m. They reported a
27.8% drop in V0 2 at VT, which was similar to our 29.7%
decrease in V0 2 at VT after 24 h of exposure to 4300 m. In
both studies, VT was defined as a disproportional increase
in VE relative to V0 2 . Because the VO 2 versus work-rate
relationship was unaffected by acute altitude exposure, the
earlier appearance of VT was due to increased submaximal
VE. Our results are also comparable with changes reported
in LT upon acute exposure to altitude (7,14,18). We
believe that increased sympathetic activity (sympatho
adrenal release of epinephrine) and glycolytic flux at a
given work rate (5) accelerated efflux of La- and H+,
which subsequently increased ventilatory drive upon acute
altitude exposure. Whereas such a proposal suggests a high
correlation between LT and VT, discrepancies in the
temporal appearance of the thresholds (13,21) have yet to
be reconciled.

A

0J_
SL

HA2

HA9

FIGURE 1-Peak exercise capacity at sea level and high altitude
(4300 m). Values are mean + SEM for AO (N = 9) and PL (N = 7).
Peak wattage (A) and VO2 (B) decreased 28% upon acute exposure to

4300 m and were not changed with acclimatization and training.
There were no differences between groups (AO, solid bars; PL, open
bars). *Different from SL; t-different from HA9; t-difference between
groups (P < 0.05).

9 d of acclimatization, and that 2) AO supplementation
improved VT upon acute, but not prolonged HA exposure.
The finding that peak exercise capacity was decreased
approximately 28% upon ascent to HA is in line with
several other investigations performed at 4300 m (10).
Although "O2peak is commonly used as an index for
physical performance at altitude, it does not accurately
reflect changes in submaximal exercise performance
typically reported. Fulco et al. (9) reported a 73% decrease
in cycling time-trial performance in our subject pool on the
third day at altitude. Others have shown a similar mismatch
between peak exercise capacity and submaximal exercise
performance in shorter time trials (3) and open-ended tests
to exhaustion at 4300 m (12,17). Recent studies have
demonstrated that power output at VT is a more accurate
measure of actual physical performance than V02p.ak
(1,16). Our findings show that acute altitude exposure
had a greater effect on power output at VT (41% decrease
in PL group) than on peak power output or V0 2 (28%
decrease); however, both assessments appeared to under
estimate changes in average power output during time-trial
performance at HA (73% decrease).
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FIGURE 2-Absolute work rates at ventilatory threshold (VT) at sea
level and high altitude (4300 m). Values are mean + SEM for AO
(N = 9) and PL (N = 7). VT (A) decreased upon acute exposure to 4300
m in both groups (AO, solid bars; PL open bars); however, the
decrease in power output (B) was attenuated in AO. After 9 d, power
output at VT improved in PL only. *Different from SL; tdifferent
from HA9; '+difference between groups (P < 0.05).
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FIGURE 3-Relative work rates at ventilatory threshold at sea level
and'high altitude (4300 m). Values are mean ± SEM for AO (N = 9)
and PL (N = 7). Relative power output (A) and V0 2 (B) at VT
decreased upon acute exposure to 4300 in in PL, but returned to SL
values after 9 d of HA acclimatization and training. Antioxidant
supplementation mitigated changes in relative power output and V0 2
at VT over the course of the study (AO, solid bars; PL, open bars).
*Different from SL; tdifferent from HA9; Idifference between groups
(P < 0.05).

The most remarkable finding of our study was that AO
supplementation attenuated the decrease in power output at
VT upon acute altitude exposure (P < 0.05). Whereas
subjects in the PL group exhibited a 41% decrease in
power output at VT, those on AO showed only a 32%
decrement. Similar results were found in terms of % Wpeak
and % VO2peak, supporting the effect of the AO supple
ment. The latter appearance of VT was suggestive of an
ergogenic effect of AO on acute altitude exposure. The
exact mechanism of action responsible for greater power
output in the AO group upon acute altitude exposure could
not be determined in this field study. Although increased
free radical production upon acute exposure to HA has
been associated with increased energy metabolism, ultra
violet light exposure and catecholamine autooxidation (2),
our results did not suggest a specific interaction between
AO supplementation and indicators of free radical damage.
We previously reported (26) that markers of oxidative
stress (plasma lipid hydroperoxides and urinary 8-hydor
oxydeoxyguanosine) were not affected during the first 5 d
of HA exposure; however, supplementation did increase
plasma concentrations of a-tocopherol and 13-carotene. The

effect, of the AO supplement may have been exerted
directly within muscle tissue (19), and thus was biochemi
cally undetectable with the indirect assessments of oxida
tive damage used in this study. Our results may be related
to those of Mohanraj et al. (19), who showed that
impairment of muscle function (-50% decrease in peak
tension), caused by increased free radical production under
hypoxic conditions, was attenuated (-18% improvement)
by AO treatment of N-acetyl-L-cysteine. Alternatively, AO
may have affected redox regulation of peripheral chemo
receptors (23); however, our data did not support an effect
of AO on hypoxic ventilatory responses (data to be
presented elsewhere). Our findings indicate that AO affect
key performance thresholds under acute hypoxia conditions
and warrant further investigations to determine specific
mechanisms of action.
The finding that acclimatization improved VT approx
imately 25% (PL group) without a change in VO2pe,ak was
novel, yet followed the pattern of improvement that Fulco
et al. (9) reported for our subject pool in time-trial
performance (14.4% improvement). Our results are also
similar to those previously reported for changes in
submaximal exercise performance (3,12,17) and lactate
versus work-rate relationships (11) during acclimatization.
We believe the reason for the delayed appearance of VT
following acclimatization was related to the lactate para
dox of altitude (24), which raises the question of why
muscle lactate efflux is reduced after acclimatization (2
3 wk) despite persistent hypoxemia. Again, whereas slight
differences exist between the net accumulation of lactate
and H+ in blood during exercise, we believe they both
follow a similar pattern of acclimatization that may reflect
sympathoadrenal release of epinephrine (24). Additionally,
we observed an 1I% increase in erythrocyte Hb over the
acclimatization period. Increased Hb may have improved
nonbicarbonate buffering capacity and delayed the appear
ance of VT; however, changes in Hb were similar between
AO and PL over the course of the study and, thus, cannot
explain differences observed between groups over time.
AO supplementation did not have a measurable effect on
VT after 9 d at altitude. Despite a 25% increase in PL VT,
AO VT was unchanged and no longer different from PL
after the acclimatization period. These results are similar to
those of Simon-Schnass and Pabst (25), who reported no
difference in LT after 15 d of supplementation with either
400 mg'd -1a-tocopherol acetate or placebo at 5000 m.
Although the assessment of physiological effects of each
supplemental AO used in this study was limited, it is
possible that the acute effect of the combination of AO
became masked by pronounced changes in sympatho
adrenal responses over the acclimatization period (24).
An additional limitation of our study was the inability to
separate independent effects of acclimatization and the
exercise program on VT. However, the design was reflective
of typical physical demands placed on individuals traveling
for extended periods to altitude (22). Given these limitations,
the slight increase in relative V0 2 at VT (% VO 2 peA) over
the course of the study (i.e., SL to HA9) was only mildly
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FIGURE 4-Individual work rates at ventilatory threshold at sea level and high altitude (4300 m). AO (N = 9) (solid squares)and PL (N = 7) (open
squares).

suggestive of a exercise training effect because neither
relative power (% Wpeak) nor relative HR (% HRpeak) at VT
was improved. Thus, we believe that the main effect on VT
was due to acclimatization and not the exercise program.

CONCLUSIONS
VT was significantly decreased upon acute altitude expo
sure, but improved with acclimatization. Changes in VT
followed patterns previously described for submaximal exer
cise performance and LT at altitude. Prior AO supplementation
improved variables associated with VT upon acute altitude
exposure, but did not have effects after a 9-d acclimatization
period. Potential effects of AO on physical performance upon
acute altitude exposure warrant further investigation.
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